Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 15/20 | 0.67 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.55 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911457 | 0.86 | GRM2 (0.69) | GRM2SLC9A1TLR8NPC1 | |
| SCHEMBL4233106 | 0.85 | GRM2 (0.49) | GRM2SLC9A1NPC1 | |
| SCHEMBL4083654 | 0.84 | GRM2 (0.47) | GRM2TLR8NPC1 | |
| SCHEMBL29356302 | 0.84 | GRM2 (0.47) | GRM2TLR8NPC1 | |
| SCHEMBL19911462 | 0.84 | GRM2 (0.47) | GRM2NPC1 | |
| SCHEMBL19911456 | 0.83 | GRM2 (0.70) | GRM2SLC9A1TLR8NPC1 | |
| SCHEMBL975383 | 0.82 | GRM2 (0.46) | GRM2SLC9A1TLR8NPC1 | |
| SCHEMBL19911463 | 0.81 | GRM2 (0.45) | GRM2NPC1 | |
| SCHEMBL10956553 | 0.81 | GRM2 (0.45) | GRM2NPC1 | |
| SCHEMBL284634 | 0.80 | GRM2 (0.65) | GRM2SLC9A1TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3467930-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018140876-A1 | NRF2 ACTIVATOR | BIOGEN MA INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| EP-3279997-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | Asahi Kasei Kabushiki Kaisha (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-20160168389-A1 | COMPOSITION INCLUDING FLUORINE-CONTAINING POLYMER COMPRISING AT LEAST ONE TYPE OF GROUP SELECTED FROM GROUP COMPRISING POLYMERIZABLE FUNCTIONAL GROUPS AND CROSS-LINKABLE FUNCTIONAL GROUPS; AND COATED ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | GRM2 2693/4885SLC9A1 341/4885TLR8 4192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.